Clinical trials
Neuroma, Acoustic trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2012 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Unknown status | 6 |
| Recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 2 |
| Assistance Publique Hopitaux De Marseille | 2 |
| Central Hospital, Nancy, France | 2 |
| University Hospital, Strasbourg, France | 2 |
| Centre Hospitalier Universitaire de Besancon | 1 |
| Hartmann Oncology Radiotherapy Group, France | 1 |
| Hospices Civils de Lyon | 1 |
| Oticon Medical | 1 |
| University Hospital, Bordeaux | 1 |
| University Hospital, Grenoble | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neuroma, Acoustic | 15 |
| Neurilemmoma | 3 |
| Dizziness | 2 |
| Brain Neoplasms | 1 |
| Endolymphatic Hydrops | 1 |
| Facial Paralysis | 1 |
| Hearing Loss, Sensorineural | 1 |
| Neurofibromatosis 2 | 1 |
| Otorhinolaryngologic Diseases | 1 |
| Peripheral Nervous System Diseases | 1 |
Trials
Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.